Hot stocks to watch this afternoon: GPRO, HAS, MU >>> READ MORE


Vertex Pharmaceuticals Incorporated (VRTX) Stock Could Burn Investors

Vertex Pharmaceuticals has a couple of built-in things working against it. Consequently, VRTX stock is hardly a name you can buy and forget. More 

Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive

VRTX stock is overpriced at the current levels. Vertex’s future holds potential, but there are quite a few possible roadblocks. More 

Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isn’t Worth the Risk

Vertex Pharmaceuticals is backed by incredible scientific innovations, but VRTX stock is still a gamble on a single, flagship treatment plan. More 

Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher

Vertex Pharmaceuticals (VRTX) is on its way to becoming the Gilead of cystic fibrosis, which could mean solid gains for VRTX stock. More 

Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons

Vertex continues to extend its dominance within cystic fibrosis treatments. But has VRTX stock run ahead of the company's potential? More 

Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock Like Its 20% Gain Never Happened

Chasing a 20% spike in Vertex Pharma (VRTX) may seem reckless, but the options market is the closest thing to a time machine in VRTX stock. More 

3 Stocks to Watch on Wednesday: Vertex Pharmaceuticals Incorporated (VRTX), CSX Corporation (CSX) and International Business Machines Corp. (IBM)

Vertex Pharmaceuticals (VRTX) soars on cystic fibrosis treatment data, CSX Corporation (CSX) falls on a restructuring charge and International Business Machines (IBM) refuses to grow. More